Plain-English translation of NCT07085598 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Epilepsy research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing vitamin D3 supplementation in men with epilepsy who have low vitamin D levels. Many epilepsy medications can cause vitamin D deficiency as a side effect. Researchers believe that vitamin D3 may help restore healthy balance in the nerves that control heart rate and function.
People with epilepsy often develop low vitamin D levels because of their seizure medications, and this deficiency may affect how well the nerves controlling the heart work. This study aims to see if adding vitamin D back can help restore normal heart nerve function.
You likely qualify if…
You likely don't qualify if…
Over 8 weeks, you will take a vitamin D3 supplement by mouth once a week (50,000 IU per dose). Before, during, and after the trial, the researchers will measure your heart's nerve function using special heart rate tests to see if the vitamin D helps. You'll need to visit the clinic for these measurements and to confirm you're taking the medication as instructed.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Bangladesh
Sponsor
Bangladesh Medical University
Enrollment target
~15 participants
Started
July 2025
Primary completion
October 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
20 Years – 40 Years
Sex
Male only
Last updated on clinicaltrials.gov in July 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Registrar, BMU
BMU
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.